On the upside
Indications that the manufacturing industry in China expanded for the first time in 13 months lifted shares of e-Commerce China Dangdang (NYSE: DANG).
The Food and Drug Administration accepted MAP Pharmaceuticals' (Nasdaq: MAPP) New Drug Application resubmission for inhaled migraine treatment Levadex.
On the downside
Electrobas (NYSE: EBR) extended its losses over concerns that rate cuts and hydroelectric dam concessions will hurt revenue.
The Securities and Exchange Commission launched an investigation into OCZ Technology (NYSE: OCZ).
Profit taking sank shares of Dynavax Technologies (Nasdaq: DVAX).
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by a margin of 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks soared 8 points to 807.